Refractory heartburn to proton pump inhibitors: epidemiology, etiology and management.
about
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazoleEosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor.The challenge of protocols for reflux disease: a review and development of a critical pathway.Medical, surgical, and endoscopic management of gastroesophageal reflux disease.
P2860
Refractory heartburn to proton pump inhibitors: epidemiology, etiology and management.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Refractory heartburn to proton pump inhibitors: epidemiology, etiology and management.
@ast
Refractory heartburn to proton pump inhibitors: epidemiology, etiology and management.
@en
type
label
Refractory heartburn to proton pump inhibitors: epidemiology, etiology and management.
@ast
Refractory heartburn to proton pump inhibitors: epidemiology, etiology and management.
@en
prefLabel
Refractory heartburn to proton pump inhibitors: epidemiology, etiology and management.
@ast
Refractory heartburn to proton pump inhibitors: epidemiology, etiology and management.
@en
P2860
P356
P1433
P1476
Refractory heartburn to proton pump inhibitors: epidemiology, etiology and management.
@en
P2093
Apostolos Mantides
Spiros N Sgouros
P2860
P304
P356
10.1159/000094789
P577
2006-07-27T00:00:00Z